UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Celgene is implementing good security practices.
Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients.
This report shows a preliminary security rating for Celgene. UpGuard scans billions of digital assets daily, in depth, across thousands of vectors. Data leak detection, vulnerability scanning and identity breach detection are just some of the advanced capabilities offered by the UpGuard platform.Get a deeper scan →
Read more about the latest issues in cybersecurity
The average cost of a data breach is now nearly $4 million, and the unfortunate truth is ...
While cyber security and information security are generally used as synonyms, there are key ...
Compare Celgene's security performance with other companies